297 related articles for article (PubMed ID: 16915299)
1. Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting.
Amira CO; Okubadejo NU
J Hum Hypertens; 2006 Nov; 20(11):894-7. PubMed ID: 16915299
[No Abstract] [Full Text] [Related]
2. [Fully possible to reduce the costs of hypertension treatment].
Wettermark B; Angman A; Hjemdahl P
Lakartidningen; 2009 Jun 3-9; 106(23):1558-62. PubMed ID: 19583013
[No Abstract] [Full Text] [Related]
3. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
[TBL] [Abstract][Full Text] [Related]
4. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
Hilleman DE; Mohiuddin SM; Lucas BD; Stading JA; Stoysich AM; Ryschon K
Clin Ther; 1994; 16(1):88-102; discussion 87. PubMed ID: 7911403
[TBL] [Abstract][Full Text] [Related]
5. [German Hypertension League update. What does the ALLHAT Study really mean?].
MMW Fortschr Med; 2003 Jun; 145(23):45-6. PubMed ID: 12854226
[No Abstract] [Full Text] [Related]
6. Following evidence-based prescribing guidelines for antihypertensives could save big bucks.
Rollins G
Rep Med Guidel Outcomes Res; 2004 Jun; 15(11):1, 6-7. PubMed ID: 15241883
[No Abstract] [Full Text] [Related]
7. How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance.
Guo JD; Liu GG; Christensen DB; Fu AZ
Value Health; 2003; 6(1):18-28. PubMed ID: 12535235
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.
Al Khaja KA; Sequeira RP
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of cost variation in different brands of antihypertensive agents.
Moharana AK; Khurana S; Lal A
J Assoc Physicians India; 1998 Jun; 46(6):573-4. PubMed ID: 11273270
[No Abstract] [Full Text] [Related]
10. Additional small amounts of diuretics improve blood pressure control at low cost without disadvantages in blood sugar metabolism.
Kudoh T; Nagawaga T; Nakagawa I
Hypertens Res; 2008 Mar; 31(3):455-62. PubMed ID: 18497464
[TBL] [Abstract][Full Text] [Related]
11. [Pharmaco-economic aspects of the treatment of hypertension].
Delporte JP; Rorive G
Rev Med Liege; 1998 May; 53(5):259-64. PubMed ID: 9689879
[TBL] [Abstract][Full Text] [Related]
12. [Hypertension in patients with ischemic heart disease].
Furukawa Y; Kimura T
Nihon Rinsho; 2004 Mar; 62 Suppl 3():465-70. PubMed ID: 15171417
[No Abstract] [Full Text] [Related]
13. [Antihypertensive pharmacotherapy of patients in primary care with either a statutory or private health insurance].
Laux G; Szecsenyi J; Miksch A; Grün B; Gutscher A; Grün B; Rosemann T; Kühlein T
Med Klin (Munich); 2009 Feb; 104(2):108-13. PubMed ID: 19242661
[TBL] [Abstract][Full Text] [Related]
14. [Medical treatment of hypertension in inpatients. Role of fixed dose combinations].
Scholz C; Höer A; Behnsen S; Haussler B
MMW Fortschr Med; 2011 Mar; 153 Suppl 1():26-32. PubMed ID: 21591328
[No Abstract] [Full Text] [Related]
15. Evaluation and management of hypertension in children and adolescents (part two): evaluation and management.
Cromwell PF; Munn N; Zolkowski-Wynne J
J Pediatr Health Care; 2005; 19(5):309-13. PubMed ID: 16202839
[No Abstract] [Full Text] [Related]
16. South Australian hypertension survey. General practitioner experiences with drug treatment.
Steven ID; Wilson DH; Wakefield MA; Beilby J; Coffey GA; Esterman AJ; Golding AP; Graham NM; Litt JC; Rohrsheim RA
Med J Aust; 1992 May; 156(9):641-4. PubMed ID: 1625618
[TBL] [Abstract][Full Text] [Related]
17. Hypertension in an urban population--who is treated with what and how well?
Li C; Hedblad B; Berglund G; Janzon L
J Hum Hypertens; 2007 Apr; 21(4):323-6. PubMed ID: 17273156
[No Abstract] [Full Text] [Related]
18. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
[TBL] [Abstract][Full Text] [Related]
19. Impact of ASCOT on hypertension treatment and guidelines in older adults.
Sheridan R; Baldwin N
Age Ageing; 2006 May; 35(3):214-7. PubMed ID: 16638764
[No Abstract] [Full Text] [Related]
20. Influencing prescribing patterns.
Huston P; Campbell NR
Can Fam Physician; 1998 Feb; 44():221-3, 228-30. PubMed ID: 9512821
[No Abstract] [Full Text] [Related]
[Next] [New Search]
